Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers

The NavDx(®) blood test analyzes tumor tissue modified viral (TTMV)-HPV DNA to provide a reliable means of detecting and monitoring HPV-driven cancers. The test has been clinically validated in a large number of independent studies and has been integrated into clinical practice by over 1000 healthca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunning, Alicia, Kumar, Sunil, Williams, Cassin Kimmel, Berger, Barry M., Naber, Stephen P., Gupta, Piyush B., Del Vecchio Fitz, Catherine, Kuperwasser, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955790/
https://www.ncbi.nlm.nih.gov/pubmed/36832208
http://dx.doi.org/10.3390/diagnostics13040725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955790/
https://www.ncbi.nlm.nih.gov/pubmed/36832208
http://dx.doi.org/10.3390/diagnostics13040725

Ejemplares similares